SEC Filing Summary: Synaptogenix, Inc. (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Synaptogenix, Inc. on February 17, 2021. The registrant is a Delaware corporation and an emerging growth company. The filing serves as a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a regulatory event rather than a financial statement.
Material Changes
No material financial changes or operational updates are detailed within the text of this specific 8-K filing. The document solely announces the furnishing of an investor presentation.
Guidance, Outlook, and Management Commentary
- Regulation FD Disclosure: The company prepared an investor presentation to be presented on February 17, 2021.
- Exhibit 99.1: The investor presentation is attached as Exhibit 99.1.
- Legal Status of Information: In accordance with General Instruction B.2, the information in this Item 7.01 and the attached presentation is "furnished" and not "filed." Consequently, it is not subject to Section 18 liabilities of the Exchange Act and is not incorporated by reference into other filings.
Key Facts for Investor Verification
- Verify the contents of Exhibit 99.1 (Investor Presentation) for actual financial data, guidance, and strategic updates, as the 8-K text itself contains no such figures.
- Confirm the company's status as an emerging growth company and its election not to use the extended transition period for new accounting standards.
- Note that the information provided is not incorporated by reference into other SEC filings.
- Clarify the discrepancy between the request metadata ("TAO Synergies Inc.") and the filing registrant ("Synaptogenix, Inc."); the filing explicitly identifies Synaptogenix, Inc.